| Literature DB >> 34218620 |
Thiago S Montenegro1, Christopher Elia1, Kevin Hines1, Zorica Buser2, Jefferson Wilson3, Zoher Ghogawala4, Shekar N Kurpad5, Daniel M Sciubba6, James S Harrop1.
Abstract
OBJECTIVE: To evaluate the use of guidelines for lumbar spine fusions among spine surgeons in North America.Entities:
Keywords: AO Spine North America; Lumbar fusion indications; North America Spine Society
Year: 2021 PMID: 34218620 PMCID: PMC8255757 DOI: 10.14245/ns.2142136.068
Source DB: PubMed Journal: Neurospine ISSN: 2586-6591
Definition of the U.S. regions
| U.S. region | U.S. states |
|---|---|
| Region 1 (Northeast) | Connecticut; Maine; Massachusetts; New Hampshire; Rhode Island; Vermont; New Jersey; New York; Pennsylvania |
| Region 2 (Midwest) | Indiana; Illinois; Michigan; Ohio; Wisconsin; Iowa; Nebraska; Kansas; North Dakota; Minnesota; Missouri; South Dakota |
| Region 3 (South) | Delaware; District of Columbia; Florida; Georgia; Maryland; North Carolina; South Carolina; Virginia; West Virginia; Alabama; Kentucky; Mississippi; Tennessee; Arkansas; Louisiana; Oklahoma; Texas |
| Region 4 (West) | Arizona; Colorado; Idaho; New Mexico; Montana; Utah; Nevada; Wyoming; Alaska; California; Hawaii; Oregon; Washington |
Fig. 1.Geographic distribution of survey respondents. The color gradient represents the number of answers per state/province.
Comparison of the Neurosurgeon and Orthopedic Surgeon group of responses
| Variable | All answers (N = 70) | Neurosurgeon (N = 21) | Orthopedic surgeon (N = 49) | p-value[ | |
|---|---|---|---|---|---|
| Total no. of NASS-discordant answers | 4.93 ± 2.01 | 4.62 ± 1.85 | 5.06 ± 2.07 | 0.403 | |
| Fellowship training | 68 (97.1) | 20 (95.2) | 48 (97.9) | 0.513 | |
| Years in practice | |||||
| 0–5 | 28 (40) | 6 (28.6) | 22 (44.9) | 0.288 | |
| 6–10 | 14 (20) | 4 (19) | 10 (20.4) | 1.000 | |
| 11–15 | 9 (13) | 4 (19) | 5 (10.2) | 0.437 | |
| 16–20 | 7 (10) | 6 (28.6) | 1 (20.4) | < 0.01[ | |
| > 20 | 12 (17.1) | 1 (4.7) | 11 (22.4) | 0.09 | |
| Approach to indicate lumbar fusion | |||||
| I do not use a specific criteria | 5 (7.1) | 1 (4.8) | 4 (8.2) | 1.000 | |
| I consider the evidence-based NASS criteria in my evaluation | 42 (60) | 13 (61.9) | 29 (59.2) | 0.831 | |
| I use another criteria | 9 (12.9) | 4 (19) | 5 (10.2) | 0.259 | |
| My indication is only based on my clinical experience | 14 (20) | 3 (14.3) | 11 (22.4) | 0.529 | |
| Region | |||||
| South | 20 (28.6) | 6 (28.6) | 14 (28.6) | 1.000 | |
| Northeast | 19 (27.1) | 5 (23.8) | 14 (28.6) | 0.776 | |
| Midwest | 16 (22.9) | 4 (19) | 12 (24.5) | 0.761 | |
| West | 9 (12.9) | 3 (14.3) | 6 (12.2) | 1.000 | |
| Canada | 6 (8.6) | 3 (14.3) | 3 (6.1) | 0.355 | |
| NASS-concordant approach (≥ 70% of NASS-concordant answers) | 44 (62.8) | 14 (66.7) | 30 (61.23) | 0.79 | |
Values are presented as mean±standard deviation or number (%).
NASS, North America Spine Society.
p < 0.05, statistically significant difference.
Fisher exact test, t-test, or Mann-Whitney test, comparing the group of Neurosurgeons with Orthopedic Surgeons.
Comparison between the respondents who stated that consider the NASS criteria in their lumbar fusion indication algorithm and the respondents who do not consider
| Variable | All answers (N = 70) | Consider NASS (N = 42) | Do not consider (N = 28) | p-value[ |
|---|---|---|---|---|
| Total no. of NASS-discordant answers | 4.93 ± 2.01 | 5.10 ± 1.96 | 4.68 ± 2.09 | 0.395 |
| Fellowship training | 68 (97.1) | 41 (97.6) | 27 (96.4) | 1.000 |
| Years in practice | 0.212 | |||
| 0–5 | 28 (40) | 15 (35.7) | 13 (46.4) | 0.457 |
| 6–10 | 14 (20) | 11 (26.2) | 3 (10.7) | 0.138 |
| 11–15 | 91 (12.9) | 4 (9.5) | 5 (17.8) | 0.468 |
| 16–20 | 7 (10) | 6 (14.3) | 1 (3.5) | 0.23 |
| > 20 | 12 (17.1) | 6 (14.3) | 6 (21.4) | 0.524 |
| Region | ||||
| South | 20 (28.6) | 13 (30.9) | 7 (25) | 0.788 |
| Northeast | 19 (27.2) | 12 (28.6) | 7 (25) | 0.79 |
| Midwest | 16 (22.9) | 7 (16.7) | 9 (32.1) | 0.155 |
| West | 9 (12.9) | 7 (16.7) | 2 (7.1) | 0.299 |
| Canada | 6 (8.6) | 3 (7.1) | 3 (10.7) | 0.677 |
| NASS-concordant approach (> = 70% of NASS-concordant answers) | 44 (62.9) | 25 (59.5) | 19 (67.9) | 0.615 |
Values are presented as mean±standard deviation or number (%).
NASS, North America Spine Society.
Fisher exact test, t-test, or Mann-Whitney test, comparing the group who consider the NASS criteria with the group who do not consider.
Analysis of the number of NASS-discordant answers stratified by specialty, fellowship training, years in practice, and region
| Variable | NASS-discordant answers | p-value | |
|---|---|---|---|
| Specialty | 0.403 | ||
| Neurosurgery | 4.62 ± 1.85 | ||
| Orthopedic Surgery | 5.06 ± 2.07 | ||
| Fellowship | 0.762 | ||
| Yes | 4.94 ± 2.02 | ||
| No | 4.5 ± 2.12 | ||
| Years in practice | 0.335 | ||
| 0–5 | 5.11 ± 1.66 | ||
| 6–10 | 4.29 ± 1.63 | ||
| 11–15 | 5.22 ± 1.92 | ||
| 16–20 | 4.00 ± 2.38 | ||
| > 20 | 5.58 ± 2.81 | ||
| Region | < 0.01[ | ||
| South | 5.75 ± 2.09 | ||
| Northeast | 3.84 ± 1.70 | ||
| Midwest | 4.06 ± 1.34 | ||
| West | 5.67 ± 1.50 | ||
| Canada | 6.83 ± 2.13 | ||
Values are presented as mean±standard deviation.
NASS, North America Spine Society.
p < 0.05, statistically significant difference.
Fig. 2.Geographic distribution of NASS-discordant answers. The color gradient represents the number of NASS-discordant answers per state/province. NASS, North America Spine Society.
Analysis of respondents who met a NASS-concordant approach compared to those that did not
| Variable | NASS-concordant approach (≥ 70% of NASS-concor- dant answers) (N = 44) | NASS-disconcordant approach (< 70% of NASS-concordant answers) (N = 26) | p-value | |
|---|---|---|---|---|
| Fellowship, yes | 43 (97.7) | 25 (96.1) | 1.000 | |
| Years in practice | ||||
| 0–5 | 19 (43.2) | 9 (34.6) | 0.615 | |
| 6–10 | 10 (22.7) | 4 (15.4) | 0.548 | |
| 11–15 | 4 (9.1) | 5 (19.2) | 0.277 | |
| 16–20 | 5 (11.3) | 2 (7.7) | 1.000 | |
| > 20 | 6 (13.6) | 6 (2.3) | 0.341 | |
| Region | ||||
| South | 8 (18.2) | 12 (46.3) | 0.01[ | |
| Northeast | 16 (36.3) | 3 (11.5) | 0.02[ | |
| Midwest | 12 (27.3) | 4 (15.4) | 0.139 | |
| West | 5 (11.4) | 4 (15.4) | 0.718 | |
| Canada | 2 (4.6) | 4 (15.4) | 0.186 | |
Values are presented as number (%).
NASS, North America Spine Society.
p < 0.05, statistically significant difference.
Survey item components with the respective number of NASS-discordant answers stratified by respondents who had a NASS-concordant approach
| No. | Question item | No. of NASS-discordant answers | |||
|---|---|---|---|---|---|
| All answers (N = 70) | NASS-concordant approach (N = 44) | NASS-discordant approach (N = 26) | p-value[ | ||
| 1 | Deformity and no physical therapy | 56 (80.0) | 36 (81.1) | 20 (76.9) | 0.759 |
| 2 | Synovial cyst | 55 (78.6) | 31 (70.4) | 24 (92.3) | 0.037 |
| 3 | Degenerative spondylolisthesis | 33 (47.1) | 18 (40.9) | 15 (57.7) | 0.219 |
| 4 | Axial LBP | 29 (41.4) | 12 (27.3) | 17 (65.4) | < 0.01[ |
| 5 | Adjacent level disease | 28 (40.0) | 12 (27.3) | 16 (61.5) | < 0.01[ |
| 6 | Recurrent stenosis | 26 (37.1) | 8 (18.2) | 18 (69.2) | < 0.01[ |
| 7 | Burst fracture | 24 (34.2) | 13 (29.5) | 11 (42.3) | 0.307 |
| 8 | Recurrent disc herniation | 20 (28.6) | 8 (18.2) | 12 (46.1) | 0.016[ |
| 9 | Foraminal stenosis | 19 (27.1) | 2 (4.5) | 17 (65.4) | < 0.01[ |
| 10 | Degenerative spondylolisthesis | 17 (24.3) | 9 (20.4) | 8 (30.1) | 0.393 |
| 11 | Deformity | 9 (12.9) | 4 (9.1) | 5 (19.2) | 0.277 |
| 12 | Pseudoarthrosis | 9 (12.9) | 3 (6.8) | 6 (23.1) | 0.068 |
| 13 | Transverse process fracture | 8 (11.4) | 3 (6.8) | 5 (19.2) | 0.137 |
| 14 | Axial LBP with a trial of nonsurgical therapy | 7 (10.0) | 2 (4.5) | 5 (19.2) | 0.093 |
| 15 | Discitis | 3 (4.3) | 1 (2.3) | 2 (7.7) | 0.551 |
| 16 | Lumbar stenosis | 1 (1.4) | 0 (0) | 1 (3.8) | 0.371 |
| 17 | Disc herniation | 1 (1.4) | 1 (2.3) | 0 (0) | 1.000 |
| 18 | Axial LBP without a trial of nonsurgical therapy | 0 (0) | 0 (0) | 0 (0) | ND[ |
Values are presented as number (%).
NASS, North America Spine Society; LBP, low back pain; ND, not done given the total cell count of the 2 groups analyzed.
p < 0.05, statistically significant difference.
Fisher exact test, comparing the group who had a NASS-concordant approach with those who had a NASS-discordant approach.
Fisher-exact test was not performed.